Celéri’s PainIntel™ offers access to various assessments for clients to use in a pain pathway (algorithm) such as PROMIS®29 for all new patients and then
January 2025 – PRESS RELEASE – January 15, 2025. Conshohocken, PA – Celéri Health has released its AI-applied large language model (LLM), PatientFinder™, for use in
January 2024 – PRESS RELEASE – January 8, 2024. Conshohocken, PA – Celéri Health is pleased to announce its collaboration with Guam Regional Medical City on
December 2023 – PRESS RELEASE – December 1, 2023. Conshohocken, PA – Celéri Health’s Research Group is pleased to announce its collaboration with Averitas Pharma on
October 2023 – PRESS RELEASE – October 24, 2023, Conshohocken, PA – Celéri Health’s technology innovation team, Celéri Labs, is pleased to announce its collaboration with
August 2023 – PRESS RELEASE – August 17, 2023, Conshohocken, PA – Celéri Health is pleased to announce its collaboration with CornerLoc™ and its pending multi-center
May 2023 – MedTech Strategist – Digital Issue Pain is individual, yet the field lacks biomarkers by which clinicians can tailor therapies to their patients. To enable more
The Role of Screening Tools According to The National Institute of Mental Health, “People with other chronic medical conditions have a higher risk of depression.”1